Chronic Spontaneous Urticaria clinical trials at UCSD
1 research study open to eligible people
open to all eligible people
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
San Diego, California and other locations
Our lead scientists for Chronic Spontaneous Urticaria research studies include Lawrence F Eichenfield, MD.